tremelimumab,durvalumab
astrazeneca,pfizer
['tremelimumab', 'durvalumab']
our expert dr. david tougeron will present a poster at #asco2022! phase-ii study evaluating #folfiri + #durvalumab and #folfiri + #durvalumab + #tremelimumab in advanced #gc or #gejc: #prodige59-durigast. 4th june 14:00 bst poster 24! #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB